已收盤 05-08 16:00:00 美东时间
-4.120
-3.29%
今日重点评级关注:Canaccord Genuity:维持Sagimet Biosciences"买入"评级,目标价从28美元升至49美元;HC Wainwright & Co.:维持Fate Therapeutics"买入"评级,目标价从5美元升至7美元
05-05 11:40
Wells Fargo analyst Gabe Hajde maintains AptarGroup (NYSE:ATR) with a Overweight and raises the price target from $144 to $145.
05-05 02:53
华盛资讯5月1日讯,阿普达公布2026财年Q1业绩,公司Q1营收9.83亿美元,同比增长10.8%,归母净利润0.73亿美元,同比下滑7.6%。
05-01 23:32
AptarGroup (NYSE:ATR) released first-quarter financial results and hosted an ea...
05-01 21:55
华盛资讯5月1日讯,阿普达公布2026财年Q1业绩,公司Q1营收9.83亿美元,同比增长10.8%,归母净利润0.73亿美元,同比下滑7.8%。
05-01 09:17
AptarGroup (NYSE:ATR) is looking for Q2 Adj EPS of $1.32-$1.40 vs $1.36 analyst estimate..
05-01 05:03
AptarGroup (NYSE:ATR) reported quarterly earnings of $1.19 per share which beat the analyst consensus estimate of $1.15 by 3.48 percent. This is a 0.83 percent decrease over earnings of $1.20 per share from the same
05-01 05:01
Companies Reporting Before The Bell • Sonic Automotive (NYSE:SAH) is projected ...
04-30 19:11
AptarGroup FY2025 publishes annual report; net sales rise to $4 billion Aptar reported higher sales and net income, and said it returned USD 486 million to shareholders through share repurchases and dividends. Stephan Tanda said he plans to retire, with Gael Touya appointed to become president and C
03-27 21:06
AptarGroup announces annual stockholders meeting; FY2025 sales rise to $3.8 billion Aptar will hold its annual meeting via live webcast on May 6, 2026. Shareholders will vote on electing four director nominees to terms expiring at the 2029 annual meeting. An advisory vote will be held on executive c
03-27 21:06